Publications by authors named "Koichiro Watanabe"

Aim: Assessing symptoms and daily functioning in patients with major depressive disorder (MDD) can be challenging, as their limited self-monitoring abilities may result in behavior observed during structured interviews not accurately reflecting their daily lives. This study aimed to determine if specific occupational behaviors could distinguish individuals with MDD from healthy individuals.

Methods: Baseline data were collected from medical records and activity programs.

View Article and Find Full Text PDF

Background: To identify risk factors for mental distress and investigate whether the factors were different between men and women during the coronavirus disease 2019 (COVID-19), using KOKOROBO data, which is an online platform that aims to facilitate access to mental health services.

Methods: We used baseline data on KOKOROBO users 13 years of age or older in Japan who accessed it from October 11, 2021, to April 6, 2023, excluding those receiving treatment for mental health problems. Global severity, based on the most severe measure on Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7), and Insomnia Severity Index (ISI), was analyzed using multivariable logistic regression with baseline characteristics for each gender, and for under 30 and 30 years of age or older in women.

View Article and Find Full Text PDF
Article Synopsis
  • * A study analyzed data from 247 SMI patients who underwent OT, looking at their social activity status before hospitalization and one year post-discharge, factoring in OT participation and other demographic variables.
  • * Findings revealed that higher OT participation rates, being socially active before hospitalization, and not having a marital history significantly predicted increased social activities after discharge.
View Article and Find Full Text PDF

Introduction: Difficult-to-treat depression (DTD) represents a broad spectrum of patients with persistent depression where standard treatment modalities are insufficient, yet specific characteristics of this group remain insufficiently understood. This investigation aims to delineate the sociodemographic and clinical profiles of suspected DTD patients in real-world clinical settings.

Method: We conducted a retrospective analysis of data from patients comprehensively evaluated for suspected DTD at Kyorin University Hospital, Tokyo, Japan, between October 2014 and September 2018.

View Article and Find Full Text PDF
Article Synopsis
  • The Japanese Society of Mood Disorders (JSMD) updated its bipolar disorder treatment guidelines in 2011, incorporating new research and aligning with the National Academy of Medicine's standards.
  • The guidelines advocate for the use of combination therapy involving mood stabilizers and second-generation antipsychotics, recognizing their effectiveness in treatment.
  • However, they face limitations, as mood stabilizers and antipsychotics were grouped together in analysis due to limited specific evidence for individual drugs, yet still offer valuable clinical support for psychiatrists in Japan.
View Article and Find Full Text PDF

Background: Bipolar disorder often emerges from depressive episodes and is initially diagnosed as depression. This study aimed to explore the effects of a prior depression diagnosis on outcomes in patients diagnosed with bipolar disorder.

Methods: This cohort study analyzed data of patients aged 18-64 years who received a new bipolar disorder diagnosis in Japan, using medical claims data from January 2005 to October 2020 provided by JMDC, Inc.

View Article and Find Full Text PDF

Introduction: While antipsychotics are often prescribed for behavioral and psychological symptoms of dementia (BPSD), typically on an off-label basis, these medications have serious adverse effects. This study investigated the long-term use of antipsychotics among inpatients with dementia displaying severe BPSD, focusing on how prescriptions change over time.

Methods: Medical charts at Kusakabe Memorial Hospital were retrospectively reviewed from October 2012 to September 2021.

View Article and Find Full Text PDF

Background: It is unclear how primary care physicians manage insomnia after the introduction of novel hypnotics such as orexin receptor antagonists and melatonin receptor agonists. This Web-based questionnaire survey aimed to examine treatment strategies for insomnia in Japanese primary care practice.

Methods: One-hundred-and-seventeen primary care physicians were surveyed on the familiarity of each management option for insomnia on a binary response scale (0 = "unfamiliar"; 1 = "familiar") and how they managed insomnia using a nine-point Likert scale (1 = "I never prescribe/perform it"; 9 = "I often prescribe/perform it").

View Article and Find Full Text PDF

Aim: Clinicians face difficulties in making treatment decisions for unspecified anxiety disorder due to the absence of any treatment guidelines. The objective of this study was to investigate how familiar and how often primary care physicians use pharmacological and nonpharmacological approaches to manage the disorder.

Methods: A survey was conducted among 117 primary care physicians in Japan who were asked to assess the familiarity of using each treatment option for unspecified anxiety disorder on a binary response scale (0 = "unfamiliar," 1 = "familiar") and the frequency on a nine-point Likert scale (1 = "never used," 9 = "frequently used").

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to assess the role of anxiety in individuals with major depressive disorder (MDD) using a Japanese version of the Clinically Useful Depression Outcome Scale (CUDOS-A) that includes DSM-5 anxious distress criteria.
  • The research involved 131 MDD patients and 200 healthy controls to evaluate the CUDOS-A's reliability and validity in measuring depression, anxiety, and related functions.
  • Results showed the CUDOS-A has strong internal consistency and reliability, effectively distinguishes between MDD patients and healthy individuals, making it a valuable tool for both research and clinical use in assessing anxious distress.
View Article and Find Full Text PDF

Background: To examine whether the "Effectiveness of Guideline for Dissemination and Education in psychiatric treatment (EGIUDE)" project affects the rate of prescriptions of hypnotic medication and the type of hypnotic medications prescribed among psychiatrists, for schizophrenia and major depressive disorder in Japan.

Methods: The EGUIDE project is a nationwide prospective study of evidence-based clinical guidelines for schizophrenia and major depressive disorder in Japan. From 2016 to 2021, clinical and prescribing data from patients discharged from hospitals participating in the EGUIDE project were used to examine hypnotic medication prescriptions The prescribing rate of hypnotics and the prescribing rate of each type of hypnotic (benzodiazepine receptor agonist, nonbenzodiazepine receptor agonist, melatonin receptor agonist, and orexin receptor antagonist) were compared among patients who had been prescribed medication by psychiatrists participating in the EGUIDE project and patients who had been prescribed medication by nonparticipating psychiatrists.

View Article and Find Full Text PDF

Objective: Depression significantly impacts the job performance and attendance of workers, leading to increased absenteeism. Predicting occupational engagement for individuals with depression is of paramount importance. This study aims to determine the cut-off score which predicts continuous employment for patients with mood disorders using the Quick Inventory of Depressive Symptomatology, Self-Report (QIDS-SR).

View Article and Find Full Text PDF

Purpose: This post hoc analysis investigated whether a patient's underlying psychiatric disease (schizophrenia/schizoaffective disorder [SCHZ] or bipolar disorder/depressive disorder [MOOD]) influenced the efficacy or safety of valbenazine for tardive dyskinesia (TD) in an Asian population.

Methods: We analyzed data from J-KINECT, a multicenter, phase II/III, randomized, double-blind study, which consisted of a 6-week placebo-controlled period followed by a 42-week extension where Japanese patients with TD received once-daily 40- or 80-mg valbenazine. We compared the change from baseline in Abnormal Involuntary Movement Scale total score and Clinical Global Impression of TD score between patients with SCHZ and those with MOOD, and incidence of treatment-emergent adverse events.

View Article and Find Full Text PDF

Aim: Interview quality is an important factor in the success of clinical trials for major depressive disorder (MDD). There is a substantial need to establish a reliable, remote clinical assessment interview system that can replace traditional in-person interviews.

Methods: We conducted a multicenter, randomized, unblinded, prospective, cross-sectional study to assess the reliability of remote interviews in patients with MDD (UMIN000041839).

View Article and Find Full Text PDF
Article Synopsis
  • Goal attainment scaling (GAS) is a patient-centered tool designed to quantify the achievement of personal goals into a standardized score, which can help in comparing outcomes across different populations, specifically for individuals with major depressive disorder (MDD).
  • In a 24-week study of Japanese outpatients with MDD treated with vortioxetine, GAS-D showed significant associations with symptom severity evaluated by the Montgomery-Åsberg Depression Rating Scale (MADRS), demonstrating that achieving goals is related to improvements in depressive symptoms.
  • The GAS-D exhibited moderate test-retest reliability and proved to be an effective measure for assessing treatment responses in MDD, suggesting it could be a valuable tool in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • Bipolar disorder is associated with social challenges, increased divorce rates, and family support loss, but there is limited evidence on divorce predictors in real-life scenarios.
  • The study analyzed data from 1071 bipolar disorder outpatients over two years, finding a 2.8% divorce rate, notably higher than the general population in Japan.
  • Factors influencing divorce included younger age and lower BMI for both genders, with men showing younger age and bipolar I as significant, while women had lower BMI and anxiolytic use as key predictors.
View Article and Find Full Text PDF

Purpose: Originally developed in English, the Oxford Depression Questionnaire (ODQ) is a patient-reported scale specifically developed for assessing emotional blunting in people with major depressive disorder (MDD). We aimed to examine the reliability and validity of the Japanese version of the ODQ.

Patients And Methods: This was a prespecified analysis of a prospective, 24-week, multicenter, observational cohort study of employed Japanese outpatients with MDD initiating treatment with vortioxetine according to the Japanese label (JRCT1031210200).

View Article and Find Full Text PDF

Aim: This study aims to examine the real-world effectiveness of education regarding clinical guidelines for psychiatric disorders using 'the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)' project.

Methods: The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e.

View Article and Find Full Text PDF

Background: Polypharmacy of additional psychotropics alongside the main treatment drug (antipsychotics in schizophrenia and antidepressants in major depressive disorder) is common in Japan. Our goal is to align psychotropic prescription in Japan with international standards, while reducing the differences between facilities. To achieve this goal, we aimed to compare prescriptions at the time of hospital admission and discharge.

View Article and Find Full Text PDF

Background: Although the costs of bipolar disorder (BD) treatments are associated with local and universal factors, data from non-Western countries remain limited. The associations between clinical features and costs of outpatient pharmacotherapy have not been well characterize. To estimate the costs of outpatient BD treatments and their associations with clinical features in a Japanese population, we investigated with special reference to the costs of medicines constituted the bulk of the total healthcare expense and were steadily increasing.

View Article and Find Full Text PDF

Objective: In patients with bipolar disorder (BD), rapid cycling (RC) presents a risk for a more severe illness, while euthymia (EUT) has a better prognosis. This study focused on the progression of RC and EUT, which are contrasting phenomenology, and aimed to clarify the influence of patient backgrounds and prescription patterns on these different progressions, using a large sample from the first and second iterations of a multicenter treatment survey for BD in psychiatric clinics (MUSUBI).

Methods: In the cross-sectional study (MUSUBI), a questionnaire based on a retrospective medical record survey of consecutive BD cases ( = 2,650) was distributed.

View Article and Find Full Text PDF
Article Synopsis
  • This study investigates effective treatments for insomnia disorder, focusing on how to use different treatments based on clinical situations and how to safely reduce or stop benzodiazepine medications.
  • Experts rated treatment options for insomnia using a nine-point scale, gathering insights from 196 professionals, which were then categorized into first-, second-, and third-line recommendations.
  • Key findings suggest that lemborexant and suvorexant are preferred first-line pharmacological treatments for both sleep initiation and maintenance, while sleep hygiene education is the top non-pharmacological recommendation.
View Article and Find Full Text PDF